Rating History for Arch Therapeutics (ARTH) by Dawson James

More Stocks Rated by Dawson James | Latest Ratings for ARTH
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/30/2023 Jason Kolbert Downgrade Neutral
(Buy)		 N/A
(N/A)		 0.60
(0.16)		 -73.33% Details